CAS: 96574-01-5; (R)-3-(3,4-Dihydroxyphenyl)-2-(((E)-3-(2-((E)-3,4-Dihydroxystyryl)-3,4-Dihydroxyphenyl)Acryloyl)Oxy)Propanoic Acid

该化合物是一种自然产生的化合物,产自Salvia Miltiorrhiza, 表现出强大的抗氧化性特性和对自由基的排泄能力. 事实证明,它具有...

结构式图片

上下游产品

丹酚酸f (E)-3-(2-((E)-3,4-Dihydroxystyryl)-3,4-Dihydroxyphenyl)Acrylic Acid 158732-59-3
(E)-3-(2-((E)-3,4-Dimethoxystyryl)-3,4-Dimethoxyphenyl)Acrylic Acid 96552-45-3
紫草酸 Lithospermic Acid 28831-65-4
丹酚酸c Salvianolic Acid C 115841-09-3

合成工艺路线路线简述

  • 121521-90-2 = 96574-01-5
    反应条件:1.1 Reagents: Acetic Acid Solvents: Dimethylformamide,Water; 3.5 H,120 °C
    标题:Method For Preparing Salvianolic Acid A
    参考文献:China
Sodium Danshensu置于吗啉,4-二甲氨基吡啶,四(三苯基膦)钯,Potassium Carbonate,盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺体系中,用 四氢呋喃,二氯甲烷,丙酮 作为反应溶剂,化学反应 56.0H,反应生成 丹酚酸 A
参考文献:由丹参素钠合成(+)-丹酚酸a
标题:由丹参素钠合成(+)-丹酚酸a
摘要:(+)-丹酚酸a是传统中药丹参中活性最高的成分之一,已通过10步合成,总收率为6.5%.从廉价的原香草醛和丹参素钠(在我们的小组中通过不对称催化合成)开始,该过程包括以下内容:Wittig反应可得到具有绝对e-构型的所需产物,Alcl 3脱甲基反应的产率令人满意,以及对烯丙基基团进行实际的脱保护以提供最终产物(+)-丹酚酸a.当前的合成技术具有使用廉价的起始原料,反应条件温和的优势,并且具有用于大规模合成的潜力.
DOI:10.1016/j.Tet.2018.08.044

海关参考信息

专利信息


专利号:US-11512075-B2
优先权日:2017-06-14
标 题:Synthesis of 20-nor-salvinorin A
发明人:SHENVI RYAN; ROACH JEREMY; SASANO YUSUKE; BOHN LAURA; SCHMID CULLEN
权利人:SCRIPPS RESEARCH INST
摘要:The invention provides 20-nor-salvinorin A, an analog of the kappa-opioid agonist salvinorin A. The 20-nor-salvinorin A is an active kappa-opioid modulator and can be used for treatment of medical conditions wherein modulation of the kappa-opioid receptor is medically indicated, such as pain, pruritis, depression, or inflammation, or conditions implicating perception and consciousness. 20-nor-salvinorin A can be less additive when used in treatment compared to a mu-opioid receptor agonist, and 20-nor-salvinorin A is more stable in vivo than is parent compound salvinorin A. The invention further provides synthetic intermediates and procedures for preparation of 20-nor-salvinorin A.

专利号:US-8716532-B2
优先权日:2009-03-27
标 题:One pot multicomponent synthesis of some novel hydroxy stilbene derivatives with alpha, beta-carbonyl conjugation under microwave irradiation
发明人:SHARMA ABHISHEK; SINHA ARUN KUMAR; KUMAR RAKESH; SHARMA NAINA
权利人:SHARMA ABHISHEK; SINHA ARUN KUMAR; KUMAR RAKESH; SHARMA NAINA; COUNCIL SCIENT IND RES
摘要:The present invention provides a method for the preparation of some novel multiconjugated 2- or 4-hydroxy substituted stilbenes. The method provides one pot multicomponent approach wherein 3-4 step reaction sequences viz. condensation, decarboxylation and Heck coupling occur simultaneously which results in an enhanced yield of desired products and reduced reaction times.

专利号:US-2012165567-A1
优先权日:2009-03-27
标 题 :One pot multicomponent synthesis of some novel hydroxy stilbene derivatives with alpha, beta-carbonyl conjugation under microwave irradiation

专利号:CN-115197851-A
优先权日:2022-05-30
标题:Penicillium difficile and its use in regulating the synthesis of tanshinones in the roots of Salvia miltiorrhiza

专利号:CN-115197851-B
优先权日:2022-05-30
标题 :Penicillium rugosa and its use in regulating the synthesis of tanshinone components in the root of Danshen

专利号:US-8507463-B2
优先权日:2005-06-13
标题 :Nucleotide analogue prodrug and the preparation thereof
发明人:YUAN JIANDONG
权利人:YUAN JIANDONG; JIANGSU CHIA TAI TIANQING PHAR; BRIGHTGENE BIO MEDICAL TECHNOLOGY CO LTD
摘要:The present invention provides: 1) Derivative solid form of 9-[2-(R)-[bis[pivaloyloxymethoxy]-phosphinylmethoxy]propyl]adenine (bis-POM PMPA, abbreviated as TD hereinafter), including crystalline form A and form B of TD, TD fumarate salts and cyclodextrin inclusion complex of TD; 2) Synthesis and purification methods of TD and Solidification method of TD oil, including converting TD oil to crystalline TD in Form A and Form B, solid TD salts and cyclodextrin inclusion complex of TD; 3) Stable pharmaceutical compositions containing TD derivatives and their preparation; 4) The use of the above TD derivatives in the antiviral treatments, especially in the treatment of HIV, HBV, CMV, HSV-1, HSV-2 and human Herpes virus infections.
潮州市泽润制药有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.zerunzy.com
电话: 0086 13818898945👤
📞潮州市泽润制药有限公司 ⚠️参考联系方式

销售电话:0086 13818898945
邮箱:jane@zerunzy.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
参考文献:10.4268/cjcmm20110411
摘要:Wang Y, Zhu J, Fu S, Zhu L, Zhang Y. [Study on chemical changes of salvianolic acid B and lithospermic acid aqueous under conditions of high temperature and high pressure]. Zhongguo Zhong Yao Za Zhi. 2011 Feb;36(4):434–8.
参考文献:10.1097/fjc.0000000000000117
摘要:Zhang XC, Chen JQ, Li B. Salvianolic acid A suppresses CCL-20 expression in TNF-α-treated macrophages and ApoE-deficient mice. J Cardiovasc Pharmacol. 2014 Oct;64(4):318–25. doi: 10.1097/fjc.0000000000000117.
参考文献:10.1007/s00216-014-7902-9
摘要:Fu Y, Mo H, Gao W, Hong J, Lu J, Li P, Chen J. Affinity selection-based two-dimensional chromatography coupled with high-performance liquid chromatography-mass spectrometry for discovering xanthine oxidase inhibitors from Radix Salviae Miltiorrhizae. Analytical and Bioanalytical Chemistry. 2014 May 28;406(20):4987–95. doi: 10.1007/s00216-014-7902-9.
参考文献:10.1002/bmc.3941
摘要:Shao Y, Zhang W, Tong L, Huang J, Li D, Nie W, Zhu Y, Li Y, Lu T. Simultaneous determination of eight bioactive components of Qishen Yiqi dripping pills in rat plasma using UFLC-MS/MS and its application to a pharmacokinetic study. Biomed Chromatogr. 2017 Aug;31(8). doi: 10.1002/bmc.3941.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知